VCAM1 and systemic lupus erythematosus: We have previously reported that circulating VCAM-1 levels can predict cardiovascular events and cardiovascular mortality in SLE36, 37, but the present study is the first to demonstrate increased numbers of EMPs expressing VCAM-1 in SLE.